Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mills

Showing results (371-380 of 393) with videos related to

Pageof 40
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|March 31, 2026
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study - RETRACTIONNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
Health Services Research|April 6, 2022
The National Heart Lung and Blood Institute Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease AllianceAbel Kho, Gail L Daumit, Kimberly P Truesdale, et al.
Journal of Affective Disorders|May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS studyMary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.
General and Comparative Endocrinology|May 4, 2012
In memory of Professor Howard A. BernE Gordon Grau, Richard S Nishioka, Alan Bern, et al.
Iscience|June 23, 2025
Interdisciplinarity at the nexus of biomedical science training: The R3 Center for Innovation in Science EducationIlinca I Ciubotariu, Tamaki Kobayashi, Crystal J Neely, et al.
Open Heart|December 18, 2024
Pulsed-field ablation of atrial fibrillation with a pentaspline catheter across National Health Service England centresMark T Mills, Saket Trivedi, Matthew J Lovell, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS studyNick Glozier, Richard Morris, Elizabeth Stratton, et al.
The New England Journal of Medicine|September 23, 2021
Race, Genetic Ancestry, and Estimating Kidney Function in CKDChi-Yuan Hsu, Wei Yang, Rishi V Parikh, et al.
The Journal of Infectious Diseases|November 28, 2019
Corrigendum to: Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military PopulationMichele D Spring, Jason C Sousa, Qigui Li, et al.
JAMA Network Open|February 17, 2026
Chronic Kidney Disease Severity and Risk of Cognitive ImpairmentZhijie Huang, Kristine Yaffe, Changwei Li, et al.
Pageof 40

Showing results (371-380 of 393) with videos related to

Sort By:
Pageof 40
The British Journal of Psychiatry : the Journal of Mental Science|March 31, 2026
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study - RETRACTIONNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
Health Services Research|April 6, 2022
The National Heart Lung and Blood Institute Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease AllianceAbel Kho, Gail L Daumit, Kimberly P Truesdale, et al.
Journal of Affective Disorders|May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS studyMary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.
General and Comparative Endocrinology|May 4, 2012
In memory of Professor Howard A. BernE Gordon Grau, Richard S Nishioka, Alan Bern, et al.
Iscience|June 23, 2025
Interdisciplinarity at the nexus of biomedical science training: The R3 Center for Innovation in Science EducationIlinca I Ciubotariu, Tamaki Kobayashi, Crystal J Neely, et al.
Open Heart|December 18, 2024
Pulsed-field ablation of atrial fibrillation with a pentaspline catheter across National Health Service England centresMark T Mills, Saket Trivedi, Matthew J Lovell, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS studyNick Glozier, Richard Morris, Elizabeth Stratton, et al.
The New England Journal of Medicine|September 23, 2021
Race, Genetic Ancestry, and Estimating Kidney Function in CKDChi-Yuan Hsu, Wei Yang, Rishi V Parikh, et al.
The Journal of Infectious Diseases|November 28, 2019
Corrigendum to: Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military PopulationMichele D Spring, Jason C Sousa, Qigui Li, et al.
JAMA Network Open|February 17, 2026
Chronic Kidney Disease Severity and Risk of Cognitive ImpairmentZhijie Huang, Kristine Yaffe, Changwei Li, et al.
Pageof 40